Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of HB-1 for Panic Disorder: A Multicenter, Randomized, Double Blind, Placebo-Controlled Trial

NCT05071430 is registered in ClinicalTrials.gov with HB BioTech, LLC as lead sponsor.

NCT NCT05071430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05071430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of HB-1 for Panic Disorder: A Multicenter, Randomized, Double Blind, Placebo-Controlled Trial
Lead sponsor
HB BioTech, LLC
Phase
Phase 2
Overall status
Completed
Start date
February 3, 2022
Completion date
December 12, 2022
Enrollment
86 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

panic disorder